IMV Inc. Presents New Positive Data from Phase 2 Monotherapy Arm of Its Decide1 Trial in Advanced Ovarian Cancer and Continued Duration of Clinical Benefits to Patients with Progression Free Survival

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology …

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology ...